Medulloblastoma, group 3 Clinical Trials
Conditions / Medulloblastoma, group 3
Delta Trials indexes 2 clinical trials for Medulloblastoma, group 3 in its publicly accessible dataset. Of these, 1 enrolling participants at this time and 1 trial have reached completion. This research takes place spanning 12 research sites around the world. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
2
Total Trials
1
Recruiting
1
Completed
0
Other Active
0
Terminated since 2020
12
Study Locations
Browse by location (12 total)
- Montréal, Canada 1 trialAll trials in Montréal, Canada
- Montréal, Canada 1 trialAll trials in Montréal, Canada
- Montréal, Canada 1 trialAll trials in Montréal, Canada
- Memphis, United States 1 trialAll trials in Memphis, United States
- Toronto, Canada 1 trialAll trials in Toronto, Canada
- Sherbrooke, Canada 1 trialAll trials in Sherbrooke, Canada
- Vancouver, Canada 1 trialAll trials in Vancouver, Canada
- Halifax, Canada 1 trialAll trials in Halifax, Canada
- Winnipeg, Canada 1 trialAll trials in Winnipeg, Canada
- Calgary, Canada 1 trialAll trials in Calgary, Canada
- Québec, Canada 1 trialAll trials in Québec, Canada
- Québec, Canada 1 trialAll trials in Québec, Canada
- Québec, Canada 1 trialAll trials in Québec, Canada
- Edmonton, Canada 1 trialAll trials in Edmonton, Canada
- Hamilton, Canada 1 trialAll trials in Hamilton, Canada
- London, Canada 1 trialAll trials in London, Canada